Centice Corporation® Hires Two Sales Professionals for its PASS Rx® Pharmacy Quality Solution

Share Article

Centice Corporation®, a pioneer in drug verification and safety products, announced today that it will expand its sales team with two new hires.

News Image
In order to continue our product and corporate growth, we are committed to hiring and retaining proven professionals. We are very excited about Gale and Ryan joining our team to further that growth with sales of the PASS Rx system.

Centice Corporation®, a pioneer in drug verification and safety products, announced today that it will expand its sales team with two new hires. Gale Massiah and Ryan Cole will serve as Sales Directors with Centice to exclusively promote and sell the company’s PASS Rx® system within the retail and hospital pharmacy markets.

PASS Rx is an easy-to-implement system that offers an extra measure of assurance that medications are being dispensed correctly by verifying the chemical composition of the contents, through the vial, within seconds. PASS Rx also provides Medi-Span® images and descriptions for the added value of a visual comparison. Ultimately the PASS Rx allows pharmacies to protect their patients from dispensing errors and themselves from litigation.

Massiah brings twenty four years of experience to Centice with a proven sales history with leaders in the Medical Devices, Biotechnology and Consumer Products industries such as McKesson, Ortho Clinical Diagnostics, Summit Instruments and Roche Biomedical. She is skilled in consultative sales, complex deals and in turning around underperforming territories. Her focus at Centice will be on providing medication error solutions to the hospital market. She graduated from Rutgers University with a Bachelor of Science, Medical Technology in 1985 and is a licensed medical technologist.

Cole brings nine years of sales experience to Centice with proven expertise in providing exceptional account management skills and delivering strong profit gains in highly competitive markets with companies such as Myriad Genetic Laboratories, Parata Systems, Biovail Pharmaceuticals and Eli Lilly & Company. His focus will be on providing the independent and small pharmacy chains with solutions in increasing patient safety, pharmacy efficiency and litigation protection. He gradutated from Ball State University with a Bachelor of Science degree in 2000.

”In order to continue our product and corporate growth, we are committed to hiring and retaining proven professionals. We are very excited about Gale and Ryan joining our team to further that growth with sales of the PASS Rx system. I am confident that both Directors will help bring continued success to the company,” said Scott Albert, Chairman of the Board and Chief Executive Officer of Centice.

To learn more, please visit contact a sales professional or download a whitepaper here.

About Centice Corporation
Centice, founded in 2004 and headquartered in Morrisville, NC, is commercializing patented and patent-pending computational sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the verification process for dispensed medications, thereby improving quality and optimizing workflow in the pharmacy. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture Partners, S-Group Direct Investments Ltd, Innovation Ventures LP, Fulcrum Financial Group, L.P. and other private investors. More information on Centice can be found at http://www.centice.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website